Project

Biotechnology netherlands

Evoducta

Many everyday products are produced through fermentation by microorganisms—some obvious, like the yoghurt you have for breakfast; others less obvious, like the citric acid in your favourite soda. The long list of industrial fermentation processes continues to grow for two key reasons: (1) They can produce complex substances that are otherwise difficult or impossible to make, such as enzymes, drugs like insulin, and various novel animal-free protein sources; (2) They enable the sustainable production of many materials without relying on fossil fuel as raw material. In short: They will play a crucial role in the protein transition and in establishing a circular economy.

Of course, the microorganisms are the central figures, and they must be carefully tailored to fit their process. Optimizing these microbial strains can take years of work by dedicated researchers and often requires advanced technology, making it is costly aspect of the research and development of a fermentation process.

Our new technology aims to revolutionize laboratory evolution methods for strain optimization. Instead of requiring daily work in the laboratory, the setup would run for months without interventions and without the need for complex equipment, making it easy to scale up.

By developing a working prototype and demonstrating our technology in real-world use cases—as part of the BiotechBooster program—we aim to empower the biotech industry to speed up innovation and meet the challenges of tomorrow.

Project team

Jeroen Koendjbiharie

Project Number

BIOB24035

Year granted

2024

Status

Ongoing

Applicant

Vrije Universiteit Amsterdam

Funding

€ 200.000

Sector/Industry

Food & Beverages, Environment, Waste, Water, Health & Pharma, Manufacturing & Production

SDG's

Zero hunger (SDG 2)
Good health and well-being (SDG 3)
Responsible consumption and production (SDG 12)

Thematic Cluster

TC1: Industrial Biotechnology & Production

Level

Level 1
Molecuul

2024

Year granted

Vrije Universiteit Amsterdam

Applicant

€ 200.000

Project funded

Nieuw medicijn tegen chronische longziekten gaat nieuwe fase in dankzij investering van 3 miljoen euro

MimeCure heeft in Addington Investment Group lead investor gevonden Het Nederlandse biotechbedrijf MimeCure heeft een investering van 3 miljoen euro

Nieuw medicijn tegen chronische longziekten gaat nieuwe fase in dankzij investering van 3 miljoen euro

Meet the Entrepreneurs: Michelle Meijer

Biotech Booster works closely together with a pool of 150+ experienced entrepreneurs who play a vital role in the program.

Meet the Entrepreneurs: Michelle Meijer

Biotech Booster announces changes in its Board of Directors

Biotech Booster announces several changes in the composition of its board of directors. The board plays a crucial role in

Biotech Booster announces changes in its Board of Directors

Biotech Booster Annual Event 2026 recap

– scroll down for the event pictures – On March 10, Biotech Booster welcomed 450+ people from the Dutch biotech

Biotech Booster Annual Event 2026 recap

How GOA Ventures Is Redefining Protein with Seaweed

There is a global surplus of seaweed. With its high protein content, this resource presents a valuable opportunity. Our Biotech

How GOA Ventures Is Redefining Protein with Seaweed

Wrapping Up Module 4: Team Dynamics, Storytelling, and the Future of Biotech

Last week, we concluded Module 4 of our Industrial Biotech Bootcamp, a collaboration between Planet B.io and Biotech Booster. This

Wrapping Up Module 4: Team Dynamics, Storytelling, and the Future of Biotech
Citaat

Biotech Booster helps us through funding and by providing us with a network to validate where we can make the best impact with our new analysis device.

Biotechnology netherlands

Carlos de Lannoy

Constellate

Citaat

What we look forward to most is leveraging the extraordinary network of Biotech Booster that we need to get foot in the market, get know-how, and understanding the competitive field which is necessary for setting up successful operations.

Biotechnology netherlands

Pim Schaasberg & Martin Pabst

ProteoT

Moleculen

Newsletter

Receive monthly updates about our community!

Subscribe to our newsletter